-
Patient Perspectives on Disease Experiences and Value of Real-Time Self-Reported Symptom and Treatment Monitoring in Locally Advanced and Metastatic Breast Cancer
Sep 9, 2025, 16:22 PM -
Impact of Dupilumab on Mental Health Service Utilization in Patients With Atopic Dermatitis in a Colombian Health Insurance Provider: An Observational Real-World Practice Study
Sep 9, 2025, 16:22 PM -
Systematic Review of Doubly Robust Methods for Population-Adjusted Indirect Comparisons
Sep 9, 2025, 16:22 PM -
Focus on Two Years of Economic Opinions on Solid Cancers (2023-2024): What Are the Specific Features vs. 2021-2022?
Sep 9, 2025, 16:22 PM -
Budget Impact of Introducing an Omalizumab Biosimilar in 23 European Countries
Sep 9, 2025, 16:22 PM -
Trends in Reimbursement Agreements for Innovative Orphan and Oncological Medicines in Spain 2020-2025
Sep 9, 2025, 16:22 PM -
The Burden and Management of Flares Among Pregnant Patients With Generalized Pustular Psoriasis (GPP): Real-World Evidence (RWE) From the Global SCRIPTOR Study
Sep 9, 2025, 16:22 PM -
Is Europe and European Evidence Development an Afterthought in Pharmaceutical Early Stage Development Decisions? An Exploratory Qualitative Survey
Sep 9, 2025, 16:22 PM -
Applying G-methods to Account for Treatment Switching in Postmarketing Effectiveness Evaluation: A Case Study of GLP-1 Receptor Agonists for Diabetic Kidney Disease
Sep 9, 2025, 16:22 PM -
Cost-Savings Assessment of Fitusiran Prophylaxis in Minimizing Breakthrough Bleeding Treatment Expenses in the United Arab Emirates
Sep 9, 2025, 16:22 PM -
Factors Impacting GKV Rebates for Orphan Drugs (OD) in Germany: A Decision Analysis Using the CRA RADAR Database
Sep 9, 2025, 16:22 PM -
Exploring Meaningful Change in Digital Health Technologies via Qualitative Interviews
Sep 9, 2025, 16:22 PM -
Pharmacoeconomic and Healthcare Aspects of the TDM-Guided Decisions on Biological Treatment of Inflammatory Diseases: Systematic Review of International Evidence
Sep 9, 2025, 16:22 PM -
How Publication Bias May Overestimate the Risk of Serious Adverse Events Associated With Bisphosphonate Use
Sep 9, 2025, 16:22 PM -
Potential Implications of EU Joint Clinical Assessment (JCA) for the UK Affiliate of a Global Pharmaceutical Company
Sep 9, 2025, 16:22 PM -
Systematic Review of Effectiveness of SGLT2 Inhibitors in Patients With Type 2 Diabetes With Focus on Glucose Levels, Cardiovascular Events, and Renal Function
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Familial Hypercholesterolemia Cascade Testing in Thailand: A Comparative Analysis of Exome vs. Long-Read DNA Sequencing
Sep 9, 2025, 16:22 PM -
Development of an AI-Powered Command-Line Agent to Support Methodological Guidance Selection in Health Economics Analysis
Sep 9, 2025, 16:22 PM -
Ukraine’s First Horizon Scanning Pilot: Lessons for HTA Implementation
Sep 9, 2025, 16:22 PM -
Prevalence and Overlap of Overweight/Obesity Type 2 Diabetes and Metabolic Dysfunction-Associated Liver Disease in England: A Clinical Practice Research Datalink Study
Sep 9, 2025, 16:22 PM
